Impact of seasonal RTS,S/AS01E vaccination plus seasonal malaria chemoprevention on the nutritional status of children in Burkina Faso and Mali

Jane Grant, Issaka Sagara, Issaka Zongo, Matthew Cairns, Rakiswendé Serge Yerbanga, Modibo Diarra, Charles Zoungrana, Djibrilla Issiaka, Frédéric Nikièma, Frédéric Sompougdou, Amadou Tapily, Mahamadou Kaya, Alassane Haro, Koualy Sanogo, Abdoul Aziz Sienou, Seydou Traore, Ismaila Thera, Hama Yalcouye, Irene Kuepfer, Paul Snell, Paul Milligan, Christian Ockenhouse, Opokua Ofori-Anyinam, Halidou Tinto, Abdoulaye Djimde, Daniel Chandramohan, Brian Greenwood, Alassane Dicko, Jean-Bosco Ouédraogo, Jane Grant, Issaka Sagara, Issaka Zongo, Matthew Cairns, Rakiswendé Serge Yerbanga, Modibo Diarra, Charles Zoungrana, Djibrilla Issiaka, Frédéric Nikièma, Frédéric Sompougdou, Amadou Tapily, Mahamadou Kaya, Alassane Haro, Koualy Sanogo, Abdoul Aziz Sienou, Seydou Traore, Ismaila Thera, Hama Yalcouye, Irene Kuepfer, Paul Snell, Paul Milligan, Christian Ockenhouse, Opokua Ofori-Anyinam, Halidou Tinto, Abdoulaye Djimde, Daniel Chandramohan, Brian Greenwood, Alassane Dicko, Jean-Bosco Ouédraogo

Abstract

Background: A recent trial in Burkina Faso and Mali showed that combining seasonal RTS,S/AS01E malaria vaccination with seasonal malaria chemoprevention (SMC) substantially reduced the incidence of uncomplicated and severe malaria in young children compared to either intervention alone. Given the possible negative effect of malaria on nutrition, the study investigated whether these children also experienced lower prevalence of acute and chronic malnutrition.

Methods: In Burkina Faso and Mali 5920 children were randomized to receive either SMC alone, RTS,S/AS01E alone, or SMC combined with RTS,S/AS01E for three malaria transmission seasons (2017-2019). After each transmission season, anthropometric measurements were collected from all study children at a cross-sectional survey and used to derive nutritional status indicators, including the binary variables wasted and stunted (weight-for-height and height-for-age z-scores below - 2, respectively). Binary and continuous outcomes between treatment groups were compared by Poisson and linear regression.

Results: In 2017, compared to SMC alone, the combined intervention reduced the prevalence of wasting by approximately 12% [prevalence ratio (PR) = 0.88 (95% CI 0.75, 1.03)], and approximately 21% in 2018 [PR = 0.79 (95% CI 0.62, 1.01)]. Point estimates were similar for comparisons with RTS,S/AS01E, but there was stronger evidence of a difference. There was at least a 30% reduction in the point estimates for the prevalence of severe wasting in the combined group compared to the other two groups in 2017 and 2018. There was no difference in the prevalence of moderate or severe wasting between the groups in 2019. The prevalence of stunting, low-MUAC-for-age or being underweight did not differ between groups for any of the three years. The prevalence of severe stunting was higher in the combined group compared to both other groups in 2018, and compared to RTS,S/AS01E alone in 2017; this observation does not have an obvious explanation and may be a chance finding. Overall, malnutrition was very common in this cohort, but declined over the study as the children became older.

Conclusions: Despite a high burden of malnutrition and malaria in the study populations, and a major reduction in the incidence of malaria in children receiving both interventions, this had only a modest impact on nutritional status. Therefore, other interventions are needed to reduce the high burden of malnutrition in these areas.

Trial registration: https://www.clinicaltrials.gov/ct2/show/NCT03143218 , registered 8th May 2017.

Keywords: Burkina Faso; Malaria; Mali; Nutrition; RTS,S/AS01E; Seasonal malaria chemoprevention.

Conflict of interest statement

OOA is an employee of the GSK group of companies and reports ownership of shares and/or restricted shares of the GSK group of companies. None of the other authors declare any competing interests.

© 2022. The Author(s).

Figures

Fig. 1
Fig. 1
Study design. ETS survey, end of transmission season survey. Adapted from Chandramohan et al. [5]
Fig. 2
Fig. 2
CONSORT Chart. Children who did not attend the first intervention contact (vaccine dose 1) were considered to have refused to participate in the trial. ETS, End of Transmission Season Survey; LFTU, lost-to-follow-up. All children that were seen at the ETS survey had their weight, height and MUAC recorded. *travelled denotes children who had temporarily travelled away from the study area at the time of the exit census but who had not permanently migrated. Adapted from Chandramohan et al. [5]
Fig. 3
Fig. 3
Prevalence of key nutritional outcomes in study children in Burkina Faso and Mali over the study period 2017–2019
Fig. 4
Fig. 4
Prevalence of moderate (a) and severe (b) nutritional outcomes in study children between study arms (SMC, RTS,S/AS01E and combined SMC + RTS,S/AS01) in Burkina Faso and Mali over the study period 2017–2019

References

    1. WHO. World malaria report 2021. Geneva, World Health Organization, 2021. . Accessed 11 Jan 2022.
    1. WHO. High burden to high impact: a targeted malaria response. Geneva, World Health Organization, 2019. . Accessed 24 Nov 2021.
    1. ACCESS-SMC Partnership Effectiveness of seasonal malaria chemoprevention at scale in west and central Africa: an observational study. Lancet. 2020;396:1829–40. doi: 10.1016/S0140-6736(20)32227-3.
    1. Greenwood B, Dicko A, Sagara I, Zongo I, Tinto H, Cairns M, et al. Seasonal vaccination against malaria: a potential use for an imperfect malaria vaccine. Malar J. 2017;16:182. doi: 10.1186/s12936-017-1841-9.
    1. Chandramohan D, Zongo I, Sagara I, Cairns M, Yerbanga R, Diarra M, et al. Seasonal malaria vaccination with or without seasonal malaria chemoprevention. N Engl J Med. 2021;385:1005–1017. doi: 10.1056/NEJMoa2026330.
    1. United Nations Children’s Fund (UNICEF), World Health Organization, International Bank for Reconstruction and Development/The World Bank. Levels and trends in child malnutrition: key findings of the 2020 edition of the joint child malnutrition estimates. Geneva; 2020.
    1. Snow RW, Molyneux CS, Njeru EK, Omumbo J, Nevill CG, Muniu E, et al. The effects of malaria control on nutritional status in infancy. Acta Trop. 1997;65:1–10. doi: 10.1016/S0001-706X(96)00601-8.
    1. Calder P, Jackson A. Undernutrition, infection and immune function. Nutr Res Rev. 2000;13:3–29. doi: 10.1079/095442200108728981.
    1. Ferreira EDA, Alexandre MA, Salinas JL, de Siqueira AM, Benzecry SG, de Lacerda MVG, et al. Association between anthropometry-based nutritional status and malaria: a systematic review of observational studies. Malar J. 2015;14:346. doi: 10.1186/s12936-015-0870-5.
    1. Nyakeriga AM, Troye-Blomberg M, Chemtai AK, Marsh K, Williams TN. Malaria and nutritional status in children living on the coast of Kenya. Am J Clin Nutr. 2004;80:1604–1610. doi: 10.1093/ajcn/80.6.1604.
    1. Muhangi L, Lule SA, Mpairwe H, Ndibazza J, Kizza M, Nampijja M, et al. Maternal HIV infection and other factors associated with growth outcomes of HIV-uninfected infants in Entebbe. Uganda Public Health Nutr. 2013;16:1548–1557. doi: 10.1017/S1368980013000499.
    1. Rowland MGM, Cole TJ, Whitehead RG. A quantitative study into the role of infection in determining nutritional status in Gambian village children. Br J Nutr. 1977;37:441–450. doi: 10.1079/BJN19770047.
    1. Gari T, Loha E, Deressa W, Solomon T, Lindtjørn B. Malaria increased the risk of stunting and wasting among young children in Ethiopia: results of a cohort study. PLoS ONE. 2018;13:e0190983. doi: 10.1371/journal.pone.0190983.
    1. D’Alessandro U, Olaleye B, Langerock P, Aikins MK, Thomson MC, Cham MK, et al. Mortality and morbidity from malaria in Gambian children after introduction of an impregnated bednet programme. Lancet. 1995;345:479–483. doi: 10.1016/S0140-6736(95)90582-0.
    1. ter Kuile FO, Terlouw DJ, Kariuki SK, Phillips-Howard PA, Mirel LB, Hawley WA, et al. Impact of permethrin-treated bed nets on malaria, anemia, and growth in infants in an area of intense perennial malaria transmission in western Kenya. Am J Trop Med Hyg. 2003;68(Suppl 4):68–77. doi: 10.4269/ajtmh.2003.68.68.
    1. Shiff C, Checkley W, Winch P, Premji Z, Minjas J, Lubega P. Changes in weight gain and anaemia attributable to malaria in Tanzanian children living under holoendemic conditions. Trans R Soc Trop Med Hyg. 1996;90:262–265. doi: 10.1016/S0035-9203(96)90240-0.
    1. Konaté AT, Yaro JB, Ouédraogo AZ, Diarra A, Gansané A, Soulama I, et al. Intermittent preventive treatment of malaria provides substantial protection against malaria in children already protected by an insecticide-treated bednet in Burkina Faso: a randomised, double-blind, placebo-controlled trial. PLoS Med. 2011;8:e1000408. doi: 10.1371/journal.pmed.1000408.
    1. Dicko A, Diallo AI, Tembine I, Dicko Y, Dara N, Sidibe Y, et al. Intermittent preventive treatment of malaria provides substantial protection against malaria in children already protected by an insecticide-treated bednet in mali: a randomised, double-blind, placebo-controlled trial. PLoS Med. 2011;8:e1000407. doi: 10.1371/journal.pmed.1000407.
    1. Ntab B, Cissé B, Boulanger D, Sokhna C, Targett G, Lines J, et al. Impact of intermittent preventive anti-malarial treatment on the growth and nutritional status of preschool children in rural Senegal (West Africa) Am J Trop Med Hyg. 2007;77:411–417. doi: 10.4269/ajtmh.2007.77.411.
    1. Danquah I, Dietz E, Zanger P, Reither K, Ziniel P, Bienzle U, et al. Reduced efficacy of intermittent preventive treatment of malaria in malnourished children. Antimicrob Agents Chemother. 2009;53:1753–1759. doi: 10.1128/AAC.01723-08.
    1. United Nations Children’s Fund (UNICEF), World Health Organization, World Bank. Joint global database on child malnutrition. 2021. . Accessed 15 June 2021.
    1. WHO. Child Growth Standards. Geneva, World Health Organization, 2007. . Accessed 3 Sep 2020.
    1. WHO. United Nations Children’s Fund . Recommendations for data collection, analysis and reporting on anthropometric indicators in children under 5 years old. Geneva: World Health Organization; 2003.
    1. Zou G. A modified Poisson regression approach to prospective studies with binary data. Am J Epidemiol. 2004;159:702–706. doi: 10.1093/aje/kwh090.
    1. Chandramohan D, Dicko A, Zongo I, Sagara I, Cairns M, Kuepfer I, et al. Seasonal malaria vaccination: protocol of a phase 3 trial of seasonal vaccination with the RTS, S/AS01 e vaccine, seasonal malaria chemoprevention and the combination of vaccination and chemoprevention. BMJ Open. 2020;10:35433.
    1. Jackson BD, Black RE. A literature review of the effect of malaria on stunting. J Nutrition. 2017;147:2163S–2168S.
    1. Gutman J, Slutsker L. Intermittent preventive treatment with sulfadoxine-pyrimethamine: more than just an antimalarial? Am J Trop Med Hyg. 2017;96:9–10. doi: 10.4269/ajtmh.16-0888.
    1. Capan M, Mombo-Ngoma G, Makristathis A, Ramharter M. Anti-bacterial activity of intermittent preventive treatment of malaria in pregnancy: comparative in vitro study of sulphadoxine-pyrimethamine, mefloquine, and azithromycin. Malar J. 2010;9:303. doi: 10.1186/1475-2875-9-303.
    1. Institut National de la Statistique (INSTAT), Cellule de Planification et de Statistique Secteur Santé-Développement Social et Promotion de la Famille (CPS/SS-DS/PF), ICF International. Mali Demographic and Health Survey 2018. Bamako, Mali and Rockville, Maryland, USA : INSTAT, CPS/SS-DS-PS and ICF. 2019. . Accessed 3 Sep 2020.

Source: PubMed

3
Abonnere